| UniProt ID | A2AP_HUMAN | |
|---|---|---|
| UniProt AC | P08697 | |
| Protein Name | Alpha-2-antiplasmin | |
| Gene Name | SERPINF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 491 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin.. | |
| Protein Sequence | MALLWGLLVLSWSCLQGPCSVFSPVSAMEPLGRQLTSGPNQEQVSPLTLLKLGNQEPGGQTALKSPPGVCSRDPTPEQTHRLARAMMAFTADLFSLVAQTSTCPNLILSPLSVALALSHLALGAQNHTLQRLQQVLHAGSGPCLPHLLSRLCQDLGPGAFRLAARMYLQKGFPIKEDFLEQSEQLFGAKPVSLTGKQEDDLANINQWVKEATEGKIQEFLSGLPEDTVLLLLNAIHFQGFWRNKFDPSLTQRDSFHLDEQFTVPVEMMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLANLSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLRGISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPMEEDYPQFGSPK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 36 | O-linked_Glycosylation | EPLGRQLTSGPNQEQ CCCCCCCCCCCCHHH | 24.25 | OGP | |
| 36 | Phosphorylation | EPLGRQLTSGPNQEQ CCCCCCCCCCCCHHH | 24.25 | 28509920 | |
| 37 | Phosphorylation | PLGRQLTSGPNQEQV CCCCCCCCCCCHHHC | 61.93 | 28509920 | |
| 37 | O-linked_Glycosylation | PLGRQLTSGPNQEQV CCCCCCCCCCCHHHC | 61.93 | OGP | |
| 45 | O-linked_Glycosylation | GPNQEQVSPLTLLKL CCCHHHCCCEEEEEC | 17.56 | OGP | |
| 48 | Phosphorylation | QEQVSPLTLLKLGNQ HHHCCCEEEEECCCC | 33.17 | 28509920 | |
| 48 | O-linked_Glycosylation | QEQVSPLTLLKLGNQ HHHCCCEEEEECCCC | 33.17 | OGP | |
| 126 | N-linked_Glycosylation | HLALGAQNHTLQRLQ HHHHHCCCHHHHHHH | 29.58 | UniProtKB CARBOHYD | |
| 126 | N-linked_Glycosylation | HLALGAQNHTLQRLQ HHHHHCCCHHHHHHH | 29.58 | 16335952 | |
| 250 | Phosphorylation | NKFDPSLTQRDSFHL CCCCCCCCCCCCCCC | 26.37 | 20068231 | |
| 295 | N-linked_Glycosylation | AHFPFKNNMSFVVLV EECCCCCCEEEEEEE | 28.24 | UniProtKB CARBOHYD | |
| 295 | N-linked_Glycosylation | AHFPFKNNMSFVVLV EECCCCCCEEEEEEE | 28.24 | 16335952 | |
| 309 | N-linked_Glycosylation | VPTHFEWNVSQVLAN EECCCCCCHHHHHHH | 19.16 | UniProtKB CARBOHYD | |
| 309 | N-linked_Glycosylation | VPTHFEWNVSQVLAN EECCCCCCHHHHHHH | 19.16 | 16335952 | |
| 316 | N-linked_Glycosylation | NVSQVLANLSWDTLH CHHHHHHHCCCCCCC | 30.37 | UniProtKB CARBOHYD | |
| 316 | N-linked_Glycosylation | NVSQVLANLSWDTLH CHHHHHHHCCCCCCC | 30.37 | 2440681 | |
| 390 | Ubiquitination | TLELSEVGVEAAAAT EEEHHHHHHHHHHHH | 13.90 | 29967540 | |
| 397 | O-linked_Glycosylation | GVEAAAATSIAMSRM HHHHHHHHHHHHHHC | 18.88 | OGP | |
| 397 | Phosphorylation | GVEAAAATSIAMSRM HHHHHHHHHHHHHHC | 18.88 | - | |
| 398 | Phosphorylation | VEAAAATSIAMSRMS HHHHHHHHHHHHHCC | 12.01 | - | |
| 405 | Phosphorylation | SIAMSRMSLSSFSVN HHHHHHCCHHHCCCC | 24.80 | - | |
| 407 | Phosphorylation | AMSRMSLSSFSVNRP HHHHCCHHHCCCCCC | 23.25 | - | |
| 410 | Phosphorylation | RMSLSSFSVNRPFLF HCCHHHCCCCCCEEE | 22.04 | - | |
| 450 | Phosphorylation | ELKEQQDSPGNKDFL HHHHCCCCCCCHHHH | 30.30 | 24505115 | |
| 454 | Ubiquitination | QQDSPGNKDFLQSLK CCCCCCCHHHHHHHC | 56.63 | 29967540 | |
| 459 | Phosphorylation | GNKDFLQSLKGFPRG CCHHHHHHHCCCCCC | 33.91 | 24972180 | |
| 459 | O-linked_Glycosylation | GNKDFLQSLKGFPRG CCHHHHHHHCCCCCC | 33.91 | OGP | |
| 484 | Phosphorylation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | 2434496 | |
| 484 | Sulfation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | - | |
| 484 | Sulfation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | 2434496 | |
| 489 | Phosphorylation | EDYPQFGSPK----- CCCCCCCCCC----- | 30.70 | 24719451 | |
| 489 | O-linked_Glycosylation | EDYPQFGSPK----- CCCCCCCCCC----- | 30.70 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of A2AP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of A2AP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of A2AP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CFAD_HUMAN | CFD | physical | 12080056 | |
| SSRA_HUMAN | SSR1 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 262850 | Alpha-2-plasmin inhibitor deficiency (APLID) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-295 AND ASN-309,AND MASS SPECTROMETRY. | |